Andrew Eugene Hendifar
Overview
Explore the profile of Andrew Eugene Hendifar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
131
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Levi A, Blais E, Davelaar J, Ebia M, Minasyan A, Nikravesh N, et al.
Oncologist
. 2025 Mar;
30(3).
PMID: 40079530
Background: Previous research demonstrates longer survival for patients with lung-only metastatic pancreatic adenocarcinoma (mPDAC) compared to liver-only mPDAC. The objective of this study is to understand the survival differences, impact...
2.
Philip P, Azar I, Xiu J, Hall M, Hendifar A, Lou E, et al.
Clin Cancer Res
. 2022 Mar;
28(12):2704-2714.
PMID: 35302596
Purpose: KRAS mutation (MT) is a major oncogenic driver in pancreatic ductal adenocarcinoma (PDAC). A small subset of PDACs harbor KRAS wild-type (WT). We aim to characterize the molecular profiles...
3.
Gower A, Golestany B, Gong J, Singhi A, Hendifar A
JCO Precis Oncol
. 2020 Sep;
4.
PMID: 32923899
No abstract available.
4.
Wang L, Gaddam S, Wang N, Xie Y, Deng Z, Zhou Z, et al.
Front Physiol
. 2020 Mar;
11:8.
PMID: 32153416
Background: Current magnetic resonance imaging (MRI) of pancreatic disease is qualitative in nature. Quantitative imaging offers several advantages, including increased reproducibility and sensitivity to detect mild or diffuse disease. The...
5.
Osipov A, Nissen N, Rutgers J, Dhall D, Naziri J, Chopra S, et al.
Ann Surg Oncol
. 2017 Sep;
24(12):3674-3682.
PMID: 28871564
Purpose: There is debate regarding the definition and clinical significance of margin clearance in pancreatic ductal adenocarcinoma (PDA). A comprehensive archival analysis of surgical resection margins was performed to determine...
6.
Iriana S, Ahmed S, Gong J, Annamalai A, Tuli R, Hendifar A
Front Oncol
. 2016 May;
6:99.
PMID: 27200288
Treatment options for advanced pancreatic ductal adenocarcinoma (PDAC) are limited; however, new therapies targeting specific tumor-related molecular characteristics may help certain patient cohorts. Emerging preclinical data have shown that inhibition...